Please login to the form below
Sanofi exits Zynquista alliance with Lexicon
Will pay $260m to end collaboration
Mallinckrodt offloads CDMO for $250m
Move follows US opioid settlement
Sumitomo Dainippon goes big on biotech with $3bn Roivant deal
Could acquire up to 11 Roivant spinouts
Boehringer bolsters KRAS push with $720m Lupin deal
Signs of progress in the field are emerging
Vertex eyes type 1 diabetes cure with biotech acquisition
Will acquire Semma Therapeutics for $950m
'Therapeutic overcrowding' could hit big pharma returns
Jefferies analysts identify most at-risk companies
FDA clears Lilly’s Taltz for ankylosing spondylitis
New indication boosts $1bn+ hopes for this year
Pfizer goes big on gene therapy with $500m facility spend
Continues to build on its growing gene therapy business
Health coverage across state lines
Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad
-
Standing out in a crowdCelltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars
-
The diseased organisationLike humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured
-
AstraZeneca buys FDA priority review voucher from SobiPicks up coveted voucher for $95m
-
Novo Nordisk shareholder revolt reaches EuropeAccused of lacking transparency over pricing pressures
-
Lundbeck’s key products shine in Q2 but problems remainFaces increasing patent losses
-
Humana lawsuit targets Mallinckrodt's 'billion-dollar golden goose'Latest twist in long story of Acthar
-
Novo Nordisk boosted by new type 2 diabetes launchesRapid uptake of newcomer Ozempic aids growth
-
Bayer takes control of BlueRock stem cell joint ventureDeal values BlueRock at $1bn
-
Boehringer posts solid first half as business revamp beds inJardiance helped to boost sales
-
New hires at Ferring, Flexion and Immunocore The latest movers in pharma
-
New hires at Nanoform, Leo Pharma and CalliditasThe latest movers in pharma and biotech
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMOLatest movers in pharma and biotech
-
New hires at Mundipharma, Sinclair Pharma and Relay TherapeuticsLatest movers in pharma
-
Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership teamThe latest industry movers
Latest sales appointments
Featured jobs
-
Account Director – UK Office
-
Excellent salary and benefits
- Client Services Director- Flexible Working
-
Negotiable
- Account Manager – Healthcare advertising
-
Salary TBC
-
Events Executive
-
DOE
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Senior Medical Writer
-
Competitive salary plus benefits
Subscribe to our email news alerts
- Novartis eyes potential new indication for Cosentyx
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- AbbVie/Allergan's merger faces public opposition
- Envision Pharma Group relocates to support expansion
- Biogen loses another pipeline drug to toxicity concerns
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Report: Customer experience, shaping digital healthcare
- The benefits of uniting in a divergent environment
- Encouraging signs in biomarker R&D
- J&J puts pressure on rivals with new Erleada okay in prostate cancer
- Pharma exhibition stand design with added value
- Bluebird Bio reveals further encouraging data for CALD gene therapy
PMHub
Novasecta
We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...
Latest intelligence
- Report: Customer experience, shaping digital healthcare
- In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
- Encouraging signs in biomarker R&D
- The cancer immunotherapy firms ramping-up biomarker R&D...
- Programmatic methodology and why you should be using it
- What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Quick links
Infographics
